{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T06:24:00Z","timestamp":1777962240249,"version":"3.51.4"},"reference-count":112,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Exosomes, acting as vital mediators of cellular communication and carriers of diverse biomolecular cargo, are increasingly documented as important participants in cancer pathogenesis and progression. When it comes to triple-negative breast cancer (TNBC), a disease that comes with significant therapeutic hurdles, finding new, non-invasive biomarkers is absolutely crucial. This systematic review considers recent research, focusing on the role of exosomal biomarkers in diagnosing, predicting prognosis and foreseeing treatment response in TNBC patients. After an extensive search across PubMed and Google Scholar, we found many exosomal molecules showing great promise for early detection, tracking disease progression and tailoring treatments. This truly highlights liquid biopsy as a valuable, minimally invasive tool. However, there are still some big challenges to treat. These include variations in methodology, the sheer diversity of samples studied and the prevalence of research in specific populations, all of which make it harder to generalize findings. It has been suggested that future research must prioritize protocol standardization, achieving a deeper understanding of underlying biological mechanisms and, crucially, developing combinatorial biomarker panels. Ultimately, the successful translation of exosomal biomarkers into clinical practice will significantly advance personalized medicine in TNBC, leading to improved patient outcomes and an enhanced quality of life.<\/jats:p>","DOI":"10.3390\/ijms27041918","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T13:15:35Z","timestamp":1771334135000},"page":"1918","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exosomes and Triple-Negative Breast Cancer: Current Knowledge and Clinical Significance"],"prefix":"10.3390","volume":"27","author":[{"given":"Maria","family":"Loukopoulou","sequence":"first","affiliation":[{"name":"Molecular Oncology Laboratory, Medical School, University of Patras, 26504 Patras, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia","family":"Kottorou","sequence":"additional","affiliation":[{"name":"Molecular Oncology Laboratory, Medical School, University of Patras, 26504 Patras, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelos","family":"Koutras","sequence":"additional","affiliation":[{"name":"Division of Oncology, Department of Medicine, University Hospital of Patras, 26504 Patras, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2402-2549","authenticated-orcid":false,"given":"Foteinos-Ioannis","family":"Dimitrakopoulos","sequence":"additional","affiliation":[{"name":"Molecular Oncology Laboratory, Medical School, University of Patras, 26504 Patras, Greece"},{"name":"Division of Oncology, Department of Medicine, University Hospital of Patras, 26504 Patras, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.cell.2016.01.043","article-title":"Communication by Extracellular Vesicles: Where We Are and Where We Need to Go","volume":"164","author":"Tkach","year":"2016","journal-title":"Cell"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1083\/jcb.201211138","article-title":"Extracellular vesicles: Exosomes, microvesicles, and friends","volume":"200","author":"Raposo","year":"2013","journal-title":"J. Cell Biol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"de la Torre Gomez, C., Goreham, R.V., Bech Serra, J.J., Nann, T., and Kussmann, M. (2018). \u201cExosomics\u201d\u2014A Review of Biophysics, Biology and Biochemistry of Exosomes with a Focus on Human Breast Milk. Front. Genet., 9.","DOI":"10.3389\/fgene.2018.00092"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1002\/jnr.25231","article-title":"Plasma versus serum for extracellular vesicle (EV) isolation: A duel for reproducibility and accuracy for CNS-originating EVs biomarker analysis","volume":"101","author":"Taha","year":"2023","journal-title":"J. Neurosci. Res."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Zhang, X., Takeuchi, T., Takeda, A., Mochizuki, H., and Nagai, Y. (2022). Comparison of serum and plasma as a source of blood extracellular vesicles: Increased levels of platelet-derived particles in serum extracellular vesicle fractions alter content profiles from plasma extracellular vesicle fractions. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0270634"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-Vizca\u00edno Mengual, E., Cordero, L., and Pinto, H. (2025). Human Blood Exosomes: Isolation and Characterization Methods, Variability, and the Need for Standardized Protocols\u2014A Review. Biomedicines, 13.","DOI":"10.3390\/biomedicines13122970"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"101613","DOI":"10.1016\/j.mtbio.2025.101613","article-title":"Exosome isolation and characterization for advanced diagnostic and therapeutic applications","volume":"31","author":"Mukerjee","year":"2025","journal-title":"Mater. Today Bio"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.3390\/ijms14035338","article-title":"Exosomes as Intercellular Signaling Organelles Involved in Health and Disease: Basic Science and Clinical Applications","volume":"14","author":"Corrado","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cell.2019.02.029","article-title":"Reassessment of Exosome Composition","volume":"177","author":"Jeppesen","year":"2019","journal-title":"Cell"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ceb.2014.05.004","article-title":"Biogenesis and secretion of exosomes","volume":"29","author":"Kowal","year":"2014","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Jankovi\u010dov\u00e1, J., Se\u010dov\u00e1, P., Michalkov\u00e1, K., and Antal\u00edkov\u00e1, J. (2020). Tetraspanins, More than Markers of Extracellular Vesicles in Reproduction. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21207568"},{"key":"ref_12","first-page":"312","article-title":"Extracellular vesicles: The future of therapeutics and drug delivery systems","volume":"2","author":"Uddin","year":"2024","journal-title":"Intell. Pharm."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12964-023-01408-6","article-title":"Protein cargo in extracellular vesicles as the key mediator in the progression of cancer","volume":"22","author":"Balvan","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Aloi, N., Drago, G., Ruggieri, S., Cibella, F., Colombo, P., and Longo, V. (2024). Extracellular Vesicles and Immunity: At the Crossroads of Cell Communication. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25021205"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1016\/j.apsb.2021.01.001","article-title":"The biology, function, and applications of exosomes in cancer","volume":"11","author":"Liu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"O\u2019Brien, J., Hayder, H., Zayed, Y., and Peng, C. (2018). Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation. Front. Endocrinol., 9.","DOI":"10.3389\/fendo.2018.00402"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41392-024-01735-1","article-title":"Extracellular vesicles as tools and targets in therapy for diseases","volume":"9","author":"Kumar","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1146\/annurev-biochem-060614-034258","article-title":"PIWI-Interacting RNA: Its Biogenesis and Functions","volume":"84","author":"Iwasaki","year":"2015","journal-title":"Annu. Rev. Biochem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12929-024-01055-0","article-title":"Exosomes: A review of biologic function, diagnostic and targeted therapy applications, and clinical trials","volume":"31","author":"Chen","year":"2024","journal-title":"J. Biomed. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/tra.12803","article-title":"The role of lipids in exosome biology and intercellular communication: Function, analytics and applications","volume":"22","year":"2021","journal-title":"Traffic"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Parameshwar, K., Anitha, K., Mounika, N., Parameshwar, R., and Narayana, N.A. (2024). Exosomes: Biogenesis, Composition, and Synthesis. Exosomes Based Drug Delivery Strategies for Brain Disorders, Springer Nature.","DOI":"10.1007\/978-981-99-8373-5_2"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12943-024-02215-4","article-title":"Emerging role of exosomes in cancer therapy: Progress and challenges","volume":"24","author":"Li","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Wang, Y., Xiao, T., Zhao, C., and Li, G. (2023). The Regulation of Exosome Generation and Function in Physiological and Pathological Processes. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25010255"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"721","DOI":"10.7150\/ijbs.79063","article-title":"Extracellular vesicles, the emerging mirrors of brain physiopathology","volume":"19","author":"Cano","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.gendis.2022.03.021","article-title":"The biogenesis and secretion of exosomes and multivesicular bodies (MVBs): Intercellular shuttles and implications in human diseases","volume":"10","author":"Xu","year":"2023","journal-title":"Genes Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12964-021-00730-1","article-title":"The exosome journey: From biogenesis to uptake and intracellular signalling","volume":"19","author":"Gurung","year":"2021","journal-title":"Cell Commun. Signal."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Krylova, S.V., and Feng, D. (2023). The Machinery of Exosomes: Biogenesis, Release, and Uptake. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021337"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s12276-024-01209-y","article-title":"Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer","volume":"56","author":"Lee","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ceb.2011.04.008","article-title":"MVB vesicle formation: ESCRT-dependent, ESCRT-independent and everything in between","volume":"23","author":"Babst","year":"2011","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"R116","DOI":"10.1016\/j.cub.2012.01.028","article-title":"The ESCRT machinery","volume":"22","author":"Schmidt","year":"2012","journal-title":"Curr. Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e201904113","DOI":"10.1083\/jcb.201904113","article-title":"ALIX- and ESCRT-III\u2013dependent sorting of tetraspanins to exosomes","volume":"219","author":"Larios","year":"2020","journal-title":"J. Cell Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12943-022-01671-0","article-title":"Exosome biogenesis: Machinery, regulation, and therapeutic implications in cancer","volume":"21","author":"Han","year":"2022","journal-title":"Mol. Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2003505","DOI":"10.1002\/advs.202003505","article-title":"Shedding Light on Extracellular Vesicle Biogenesis and Bioengineering","volume":"8","author":"Teng","year":"2021","journal-title":"Adv. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Komori, T., and Fukuda, M. (2024). Two roads diverged in a cell: Insights from differential exosome regulation in polarized cells. Front. Cell Dev. Biol., 12.","DOI":"10.3389\/fcell.2024.1451988"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1056\/NEJMra1001389","article-title":"Triple-Negative Breast Cancer","volume":"363","author":"Foulkes","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_36","first-page":"113","article-title":"Molecular Biology Mechanisms and Emerging Therapeutics of Triple-Negative Breast Cancer","volume":"17","author":"Zhang","year":"2023","journal-title":"Biologics"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1002\/1878-0261.13765","article-title":"Integrative analysis of circulating tumor cells (CTCs) and exosomes from small-cell lung cancer (SCLC) patients: A comprehensive approach","volume":"19","author":"Papakonstantinou","year":"2025","journal-title":"Mol. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Dimitrakopoulos, F.I., Kottorou, A.E., Rodgers, K., Sherwood, J.T., Koliou, G.A., Lee, B., Yang, A., Brahmer, J.R., Baylin, S.B., and Yang, S.C. (2021). Clinical Significance of Plasma CD9-Positive Exosomes in HIV Seronegative and Seropositive Lung Cancer Patients. Cancers, 13.","DOI":"10.3390\/cancers13205193"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Kottorou, A., Dimitrakopoulos, F.I., Diamantopoulou, G., Kalofonou, F., Stavropoulos, M., Thomopoulos, K., Makatsoris, T., Koutras, A., and Kalofonos, A. (2023). Small Extracellular Vesicles (sEVs) Biogenesis Molecular Players Are Associated with Clinical Outcome of Colorectal Cancer Patients. Cancers, 15.","DOI":"10.3390\/cancers15061685"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12943-025-02282-1","article-title":"Extracellular vesicles in cancer\u2019s communication: Messages we can read and how to answer","volume":"24","author":"Semeradtova","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Weaver, J.W., Zhang, J., Rojas, J., Musich, P.R., Yao, Z., and Jiang, Y. (2022). The application of exosomes in the treatment of triple-negative breast cancer. Front. Mol. Biosci., 9.","DOI":"10.3389\/fmolb.2022.1022725"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Duan, S.L., Fu, W.J., Jiang, Y.K., Peng, L.S., Ousmane, D., Zhang, Z.J., and Wang, J.-P. (2023). Emerging role of exosome-derived non-coding RNAs in tumor-associated angiogenesis of tumor microenvironment. Front. Mol. Biosci., 10.","DOI":"10.3389\/fmolb.2023.1220193"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Ashekyan, O., Abdallah, S., Shoukari, A.A., Chamandi, G., Choubassy, H., Itani, A.R.S., Alwan, N., and Nasr, R. (2022). Spotlight on Exosomal Non-Coding RNAs in Breast Cancer: An In Silico Analysis to Identify Potential lncRNA\/circRNA-miRNA-Target Axis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23158351"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"113666","DOI":"10.1016\/j.intimp.2024.113666","article-title":"Continued attention: The role of exosomal long non-coding RNAs in tumors over the past three years","volume":"144","author":"Cao","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Yang, X., Zhang, Y., Zhang, Y., Zhang, S., Qiu, L., Zhuang, Z., Wei, M., Deng, X., Wang, Z., and Han, J. (2021). The Key Role of Exosomes on the Pre-metastatic Niche Formation in Tumors. Front. Mol. Biosci., 8.","DOI":"10.3389\/fmolb.2021.703640"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"461","DOI":"10.20517\/evcna.2023.37","article-title":"Extracellular vesicles and particles as mediators of long-range communication in cancer: Connecting biological function to clinical applications","volume":"4","author":"Asao","year":"2023","journal-title":"Extracell. Vesicles Circ. Nucleic Acids"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Liu, L., Jiang, D., Bai, S., Zhang, X., and Kang, Y. (2024). Research progress of exosomes in drug resistance of breast cancer. Front. Bioeng. Biotechnol., 11.","DOI":"10.3389\/fbioe.2023.1214648"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Liao, X.W., Gao, J.B., Sun, H., Chen, H.D., Zheng, M.H., Han, L., Chen, X.-G., Su, Y.-N., Pan, D.-L., and Wu, M. (2025). Prediction of neoadjuvant chemotherapy efficacy and prognostic biomarker analysis in patients with triple-negative breast cancer. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1553831"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"339","DOI":"10.15171\/apb.2017.041","article-title":"The Different Mechanisms of Cancer Drug Resistance: A Brief Review","volume":"7","author":"Mansoori","year":"2017","journal-title":"Adv. Pharm. Bull."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Li, J., Gao, N., Gao, Z., Liu, W., Pang, B., Dong, X., Li, Y., and Fan, T. (2021). The Emerging Role of Exosomes in Cancer Chemoresistance. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.737962"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/s41598-018-19339-5","article-title":"Exosome-mediated breast cancer chemoresistance via miR-155 transfer","volume":"8","author":"Santos","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.4081\/ejh.2022.3529","article-title":"Docetaxel-resistant triple-negative breast cancer cell-derived exosomal lncRNA LINC00667 reduces the chemosensitivity of breast cancer cells to docetaxel via targeting miR-200b-3p\/Bcl-2 axis","volume":"66","author":"Li","year":"2022","journal-title":"Eur. J. Histochem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/s41419-020-03189-z","article-title":"Exosomes and breast cancer drug resistance","volume":"11","author":"Dong","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Xiong, N., Wu, H., and Yu, Z. (2024). Advancements and challenges in triple-negative breast cancer: A comprehensive review of therapeutic and diagnostic strategies. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1405491"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Youssef, E., Palmer, D., Fletcher, B., and Vaughn, R. (2025). Exosomes in Precision Oncology: From Bench to Bedside in Diagnostics and Therapeutics. Cancers, 17.","DOI":"10.20944\/preprints202501.1036.v1"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Dong, M., Liu, Q., Xu, Y., and Zhang, Q. (2022). Extracellular Vesicles: The Landscape in the Progression, Diagnosis, and Treatment of Triple-Negative Breast Cancer. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.842898"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.7150\/thno.113650","article-title":"Exosomes: Innovative biomarkers leading the charge in non-invasive cancer diagnostics","volume":"15","author":"Li","year":"2025","journal-title":"Theranostics"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12967-021-03215-4","article-title":"The role of Exosomal miRNAs in cancer","volume":"20","author":"Li","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12951-020-00767-3","article-title":"Genomic instability-derived plasma extracellular vesicle-microRNA signature as a minimally invasive predictor of risk and unfavorable prognosis in breast cancer","volume":"19","author":"Bao","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"7006","DOI":"10.1002\/cam4.2572","article-title":"A five-miRNA panel in plasma was identified for breast cancer diagnosis","volume":"8","author":"Li","year":"2019","journal-title":"Cancer Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"9650","DOI":"10.18632\/oncotarget.2520","article-title":"Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients","volume":"5","author":"Eichelser","year":"2014","journal-title":"Oncotarget"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/1354750X.2024.2406520","article-title":"Serum exosomal miR-200c is a potential diagnostic biomarker for breast cancer","volume":"29","author":"Qiao","year":"2024","journal-title":"Biomarkers"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"749","DOI":"10.4103\/jcrt.jcrt_280_21","article-title":"Detection significance of miR-3662, miR-146a, and miR-1290 in serum exosomes of breast cancer patients","volume":"17","author":"Li","year":"2021","journal-title":"J. Cancer Res. Ther."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Kan, J.Y., Shih, S.L., Yang, S.F., Chu, P.Y., Chen, F.M., Li, C.L., Wu, Y.C., Yeh, Y.T., Hou, M.F., and Chiang, C.P. (2024). Exosomal microRNA-92b Is a Diagnostic Biomarker in Breast Cancer and Targets Survival-Related MTSS1L to Promote Tumorigenesis. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25021295"},{"key":"ref_65","first-page":"7303","article-title":"Identification of serum exosomal miR-148a as a novel prognostic biomarker for breast cancer","volume":"24","author":"Li","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14737159.2023.2195552","article-title":"Diagnostic and predictive value of liquid biopsy-derived exosome miR-21 for breast cancer: A systematic review and meta-analysis","volume":"23","author":"Wang","year":"2023","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13058-016-0753-x","article-title":"Plasma exosome microRNAs are indicative of breast cancer","volume":"18","author":"Hannafon","year":"2016","journal-title":"Breast Cancer Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"13595","DOI":"10.1038\/s41598-019-50084-5","article-title":"Novel breast cancer screening: Combined expression of miR-21 and MMP-1 in urinary exosomes detects 95% of breast cancer without metastasis","volume":"9","author":"Ando","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s40291-020-00453-y","article-title":"Urinary Exosomal MicroRNAs as Potential Non-invasive Biomarkers in Breast Cancer Detection","volume":"24","author":"Hirschfeld","year":"2020","journal-title":"Mol. Diagn. Ther."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.1111\/cas.15155","article-title":"Multi-miRNA panel of tumor-derived extracellular vesicles as promising diagnostic biomarkers of early-stage breast cancer","volume":"112","author":"Kim","year":"2021","journal-title":"Cancer Sci."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Stevic, I., M\u00fcller, V., Weber, K., Fasching, P.A., Karn, T., Marm\u00e9, F., Schem, C., Stickeler, E., Denkert, C., and van Mackelenbergh, M. (2018). Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial. BMC Med., 16.","DOI":"10.1186\/s12916-018-1163-y"},{"key":"ref_72","first-page":"240","article-title":"Differentially expressed microRNAs in exosomes of patients with breast cancer revealed by next generation sequencing","volume":"43","author":"Wu","year":"2019","journal-title":"Oncol. Rep."},{"key":"ref_73","first-page":"458","article-title":"Serum exosomal miR-335-5p serves as a diagnostic biomarker of triple-negative breast cancer","volume":"6","author":"Yao","year":"2021","journal-title":"Chin. J. Endocr. Surg."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Ozawa, P.M.M., Viera, E., Lemos, D.S., Souza, I.L.M., Zanata, S.M., Pankievicz, V.C., Tuleski, T.R., Souza, E.M., Wowk, P.F., and de Andrade Urban, C. (2020). Identification of miRNAs Enriched in Extracellular Vesicles Derived from Serum Samples of Breast Cancer Patients. Biomolecules, 10.","DOI":"10.3390\/biom10010150"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Choudhary, A., Poojary, S.S., Jain, P., Chaturvedi, H., and Das, B.C. (2026). Identification of novel exosomal miRNAs and their role in diagnosis and prognosis of Triple Negative Breast Cancer. BMC Cancer, 26.","DOI":"10.1186\/s12885-025-15499-6"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Thakur, S., Grover, R.K., Gupta, S., Yadav, A.K., and Das, B.C. (2016). Identification of Specific miRNA Signature in Paired Sera and Tissue Samples of Indian Women with Triple Negative Breast Cancer. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0158946"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1200\/JCO.2020.38.15_suppl.3528","article-title":"Exosomal circular RNAs derived from serum: Promising biomarkers for therapeutic targets and prognosis of triple-negative breast cancer (TNBC)","volume":"38","author":"Yang","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12943-024-02037-4","article-title":"Exosomal circSIPA1L3-mediated intercellular communication contributes to glucose metabolic reprogramming and progression of triple negative breast cancer","volume":"23","author":"Liang","year":"2024","journal-title":"Mol. Cancer"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.molimm.2025.02.014","article-title":"circSTIL mediates pirarubicin inhibiting the malignant phenotype of triple-negative breast cancer and acts as a biomarker in plasma exosomes","volume":"180","author":"Ji","year":"2025","journal-title":"Mol. Immunol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41419-021-03680-1","article-title":"Tumor-derived exosomal circPSMA1 facilitates the tumorigenesis, metastasis, and migration in triple-negative breast cancer (TNBC) through miR-637\/Akt1\/\u03b2-catenin (cyclin D1) axis","volume":"12","author":"Yang","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"7602","DOI":"10.1111\/jcmm.16009","article-title":"Serum exosomal lncRNA XIST is a potential non-invasive biomarker to diagnose recurrence of triple-negative breast cancer","volume":"25","author":"Lan","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"ref_82","first-page":"154","article-title":"Upregulation of serum exosomal SUMO1P3 predicts unfavorable prognosis in triple negative breast cancer","volume":"25","author":"Xu","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"100121","DOI":"10.1016\/j.mcpro.2021.100121","article-title":"Proteomic Landscape of Exosomes Reveals the Functional Contributions of CD151 in Triple-Negative Breast Cancer","volume":"20","author":"Li","year":"2021","journal-title":"Mol. Cell. Proteom."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13058-020-1251-8","article-title":"Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis","volume":"22","author":"Chaudhary","year":"2020","journal-title":"Breast Cancer Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"13572","DOI":"10.1038\/s41598-020-70393-4","article-title":"The proteomic analysis of breast cell line exosomes reveals disease patterns and potential biomarkers","volume":"10","author":"Risha","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3892\/ol.2021.13080","article-title":"Exosomal miRNA profiles of triple negative breast cancer in neoadjuvant treatment","volume":"22","author":"Sueta","year":"2021","journal-title":"Oncol. Lett."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13058-019-1109-0","article-title":"Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy","volume":"21","author":"Ortega","year":"2019","journal-title":"Breast Cancer Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.canlet.2016.09.013","article-title":"Breast cancer-secreted miR-939 downregulates VE-cadherin and destroys the barrier function of endothelial monolayers","volume":"384","author":"Regondi","year":"2017","journal-title":"Cancer Lett."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.7150\/jca.100619","article-title":"LINC00899 suppresses the progression of triple-negative breast cancer via the miRNA-425\/PTEN axis and is a biomarker for neoadjuvant chemotherapy efficacy","volume":"16","author":"Niu","year":"2025","journal-title":"J. Cancer"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Ye, F., Liang, Y., Wang, J., Song, J., Jin, Y., Wang, L., Luo, D., Li, X., Li, Y., and Han, D. (2025). A novel peptide MIB1-223aa encoded by exosomal circMIB1 from cancer-associated fibroblasts drives triple-negative breast cancer metastasis and stemness via stabilizing MIB1 to activate Notch signaling. J. Adv. Res., in press.","DOI":"10.1016\/j.jare.2025.06.023"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"117535","DOI":"10.1016\/j.cca.2023.117535","article-title":"A serum LncRNA signature for predicting prognosis of triple-negative breast cancer","volume":"549","author":"Zhu","year":"2023","journal-title":"Clin. Chim. Acta"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cca.2019.11.032","article-title":"Diagnostic and prognostic value of the cancer-testis antigen lactate dehydrogenase C4 in breast cancer","volume":"503","author":"Cui","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Jung, H.H., Kim, J.Y., Cho, E.Y., Lee, J.E., Kim, S.W., Nam, S.J., Park, Y.H., Ahn, J.S., and Im, Y.H. (2023). A Retrospective Exploratory Analysis for Serum Extracellular Vesicles Reveals APRIL (TNFSF13), CXCL13, and VEGF-A as Prognostic Biomarkers for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242115576"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41392-024-01823-2","article-title":"Tumor biomarkers for diagnosis, prognosis and targeted therapy","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e1376153","DOI":"10.1080\/2162402X.2017.1376153","article-title":"Elevated levels of extracellular vesicles are associated with therapy failure and disease progression in breast cancer patients undergoing neoadjuvant chemotherapy","volume":"7","author":"Bittner","year":"2018","journal-title":"Oncoimmunology"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3390\/curroncol29020055","article-title":"Circulating Exosomal microRNAs as Predictive Biomarkers of Neoadjuvant Chemotherapy Response in Breast Cancer","volume":"29","author":"Todorova","year":"2022","journal-title":"Curr. Oncol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejca.2020.08.020","article-title":"Immunosuppressive profiles in liquid biopsy at diagnosis predict response to neoadjuvant chemotherapy in triple-negative breast cancer","volume":"139","author":"Santaballa","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41419-017-0030-7","article-title":"MiR-770 suppresses the chemo-resistance and metastasis of triple negative breast cancer via direct targeting of STMN1","volume":"9","author":"Li","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e38549","DOI":"10.1097\/MD.0000000000038549","article-title":"Correlative expression of exosomal miRNAs in chemotherapy resistance of triple-negative breast cancer: An observational study","volume":"103","author":"Yang","year":"2024","journal-title":"Medicine"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/s41419-021-03963-7","article-title":"Exosomal annexin A6 induces gemcitabine resistance by inhibiting ubiquitination and degradation of EGFR in triple-negative breast cancer","volume":"12","author":"Li","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Raimondi, L., Raimondi, F.M., Lazzeroni, R., Di Benedetto, L., Cimino, G., and Spinelli, G.P. (2021). Prediction of response to atezolizumab plus nab-paclitaxel in unresectable locally advanced triple-negative breast cancer (TNBC): The clinical usefulness of PD-L1 mRNA expression in plasma-derived exosomes. Preprints.","DOI":"10.20944\/preprints202103.0777.v1"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1056\/NEJMoa1809615","article-title":"Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer","volume":"379","author":"Schmid","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Qi, Y., Yan, X., Wang, C., Cao, H., and Liu, G. (2022). Predictive value of PD-L1 expression to the efficacy of immune checkpoint inhibitors in advanced triple-negative breast cancer: A systematic review and meta-analysis. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.1004821"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"e2303175","DOI":"10.1002\/advs.202303175","article-title":"Challenges Coexist with Opportunities: Spatial Heterogeneity Expression of PD-L1 in Cancer Therapy","volume":"11","author":"Wang","year":"2024","journal-title":"Adv. Sci."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Kansha, T., Ma, X., Wang, H., Yu, X., Song, Y., Guo, Z., Song, J., Xue, L., and Yang, J. (2025). Exosomal PD-L1 detection in cancer predictive biomarker for response to immune checkpoint blockade therapy. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1603855"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Zhou, K., Guo, S., Li, F., Sun, Q., and Liang, G. (2020). Exosomal PD-L1: New Insights into Tumor Immune Escape Mechanisms and Therapeutic Strategies. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.569219"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Wu, Y., Fu, H., Hao, J., Yang, Z., Qiao, X., Li, Y., Zhao, R., Lin, T., Wang, Y., and Wang, M. (2024). Tumor-derived exosomal PD-L1: A new perspective in PD-1\/PD-L1 therapy for lung cancer. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1342728"},{"key":"ref_108","first-page":"001","article-title":"Triple Negative Breast Cancer\u2014An Overview","volume":"2013","author":"Aysola","year":"2013","journal-title":"Hered. Genet."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"100297","DOI":"10.1016\/j.jlb.2025.100297","article-title":"Enhancing detection and monitoring of circulating tumor cells: Integrative approaches in liquid biopsy advances","volume":"8","author":"Velpula","year":"2025","journal-title":"J. Liq. Biopsy"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"011503","DOI":"10.1063\/1.5087122","article-title":"Challenges and opportunities in exosome research\u2014Perspectives from biology, engineering, and cancer therapy","volume":"3","author":"Li","year":"2019","journal-title":"APL Bioeng."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s11010-023-04756-6","article-title":"Global trend in exosome isolation and application: An update concept in management of diseases","volume":"479","author":"Omrani","year":"2024","journal-title":"Mol. Cell. Biochem."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.canlet.2019.12.046","article-title":"Exosomes in triple negative breast cancer: Garbage disposals or Trojan horses?","volume":"473","author":"Goh","year":"2020","journal-title":"Cancer Lett."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/4\/1918\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T13:16:45Z","timestamp":1771334205000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/4\/1918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":112,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["ijms27041918"],"URL":"https:\/\/doi.org\/10.3390\/ijms27041918","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]}}}